Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Survey: Supportive oncodermatology program improves QOL for cancer patients

Key clinical point: Participation in a supportive program may improve quality of life in cancer patients with dermatologic effects from treatment.

Major finding: Average quality of life scores declined from significantly from 6.5 to 3.8 among participants.

Study details: A survey of 34 participants in a supportive oncodermatology clinic.

Disclosures: This study was funded by a La Roche–Posay grant. Ms. Aizman reported having no disclosures. One coauthor reported relationships involving consulting and/or honoraria with several companies, including La Roche–Posay.

Citation:

Aizman L et al. J Drugs Dermatol. 2020 Apr 17. doi: 10.36849/JDD.2020.5040.